2017-03-10,VTv Therapeutics To Present At Two Upcoming Annual Investor Conferences
2017-02-27,VTv Therapeutics Reports 2016 Fourth Quarter And Full Year Financial And Operational Results And Recent Highlights
2016-12-14,VTv Therapeutics Announces Positive Topline Results From Phase 2 Study Of TTP273 In Type 2 Diabetes
2016-11-16,New Pre-Clinical Data On A VTv Therapeutics Small Molecule Drug Candidate Against Parkinson's Disease To Be Presented At The Society For Neuroscience 2016 Meeting In San Diego
2016-11-10,VTv Therapeutics To Participate In Upcoming Mizuho, Stifel And Piper Jaffray Conferences
2016-11-02,VTv Therapeutics Reports Third Quarter Financial And Operational Results And Recent Highlights
2016-10-24,VTv Therapeutics To Present At Peptide Therapeutics Symposium
2016-10-03,VTv Therapeutics To Present At Neuro Advance Boston
2016-09-08,VTv Therapeutics To Present At The Rodman & Renshaw Global Investment Conference
2016-09-07,VTv Therapeutics Completes Enrollment Of Part A Of Pivotal Phase 3 Trial Evaluating Azeliragon For The Treatment Of Patients With Mild Alzheimer's Disease
2016-09-02,VTv Therapeutics To Present At The International Psychogeriatric Association International Congress
2016-08-16,VTv Therapeutics Completes Enrollment Of Phase 2 Trial Evaluating TTP273 For The Treatment Of Type 2 Diabetes
2016-08-10,VTv Therapeutics Announces Positive Initial Topline Results From Phase 2b Study Of Glucokinase Activator TTP399 In Type 2 Diabetes
2016-07-27,VTv Therapeutics Announces Presentation Of Phase 2b Azeliragon Results At The 2016 Alzheimer's Association International Conference (AAIC)
2016-07-14,VTv Therapeutics Announces Phase 2b Azeliragon Data Selected For Oral Presentation At The 2016 Alzheimer's Association International Conference
2016-07-06,VTv Therapeutics To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference
2016-06-14,VTv Therapeutics Presents Positive Results From A Pilot Study Of Its Glucokinase Activator At American Diabetes Association 76th Scientific Sessions
2016-05-12,VTv Therapeutics Reports First Quarter Financial And Operational Results
2016-04-20,VTv Therapeutics Presents Data On Two Diabetes Candidates At Keystone Symposia On New Therapeutics For Diabetes And Obesity
2016-04-13,5 Stocks With Big Insider Buying
2016-04-12,VTv Therapeutics Announces Presentations On Its Diabetes Product Candidates TTP273 And TTP399 At The Keystone Symposia On New Therapeutics For Diabetes And Obesity
2016-04-06,VTv Therapeutics To Present At The 15th Annual Needham Healthcare Conference
2016-03-04,VTv Therapeutics To Present At Two Investor Conferences In March
2016-03-01,VTv Therapeutics Reports Fourth Quarter And Full Year 2015 Financial And Operational Results And Recent Highlights
2016-02-22,VTv Therapeutics Reports Preclinical And Clinical Results On Its Diabetes Candidate TTP273
2016-02-09,VTv Therapeutics Completes Enrollment Of Phase 2b Trial Evaluating TTP399 For The Treatment Of Type 2 Diabetes
2016-01-28,VTv Therapeutics To Present At The 18th Annual BIO CEO & Investor Conference
2016-01-21,VTv Therapeutics Initiates Phase 2 Trial Evaluating TTP273 For The Treatment Of Type 2 Diabetes
2016-01-07,5 Stocks Under $10 Set to Soar
2015-12-02,VTv Therapeutics Announces Larry Altstiel To Serve As Chief Medical Officer
2015-11-24,VTv Therapeutics To Participate In Fireside Chat At Piper Jaffray 27th Annual Healthcare Conference
2015-11-13,VTv Therapeutics To Present At Stifel 2015 Healthcare Conference
2015-11-12,VTv Therapeutics Reports Financial Results For The Third Quarter Ended September 30, 2015
2015-10-22,VTv Therapeutics To Present At The 8th Clinical Trials On Alzheimer's Disease (CTAD) Conference
2015-09-23,VTv Therapeutics To Present At Ladenburg Thalmann 2015 Healthcare Conference
2015-09-04,5 Stocks Ready for Breakouts
2015-09-01,3 Breakout Biotech Stocks Trading for Under $10
,
,
,
,
